The epidemiology of imported and locally-acquired dengue in Australia, 2012-2022.

arbovirus imported infection infectious disease notifiable disease surveillance travel

Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
18 Jan 2024
Historique:
received: 12 12 2023
revised: 15 01 2024
medline: 20 1 2024
pubmed: 20 1 2024
entrez: 20 1 2024
Statut: aheadofprint

Résumé

Dengue is the most important arboviral disease globally, and poses ongoing challenges for control including in non-endemic countries with competent mosquito vectors at risk of local transmission through imported cases. We examined recent epidemiological trends in imported and locally-acquired dengue in Australia, where the Wolbachia mosquito population replacement method was implemented throughout dengue-prone areas of northern Queensland between 2011-2019. We analysed dengue cases reported to the Australian National Notifiable Disease Surveillance System (NNDSS) between January 2012 and December 2022, and Australian traveller movement data. Between 2012 and 2022, 13 343 dengue cases were reported in Australia (median 1466 annual cases); 12 568 cases (94.2%) were imported, 584 (4.4%) were locally acquired and 191 (1.4%) had no origin recorded. Locally-acquired cases decreased from a peak in 2013 (n = 236) to zero in 2021-2022. Annual incidence of imported dengue ranged from 8·29/100000 (n = 917 cases) to 22·10/100000 (n = 2203) annual traveller movements between 2012 and 2019, decreased in 2020 (6·74/100000 traveller movements; n = 191) and 2021 (3·32/100000 traveller movements; n = 10) during COVID-19-related border closures, then rose to 34·79/100000 traveller movements (n = 504) in 2022. Imported cases were primarily acquired in Southeast Asia (n = 9323; 74%), Southern and Central Asia (n = 1555; 12%) and Oceania (n = 1341; 11%). Indonesia (n = 5778; 46%) and Thailand (n = 1483; 12%) were top acquisition countries. DENV-2 (n = 2147; 42%) and DENV-1 (n = 1526; 30%) were predominant serotypes. Our analysis highlights Australia's successful control of locally-acquired dengue with Wolbachia. Imported dengue trends reflect both Australian travel destinations and patterns and local epidemiology in endemic countries. AS is supported by a National Health and Medical Research (NHMRC) Postgraduate Scholarship (grant number 2002792), SLM by NHMRC Investigator Grants (grant number 2017229), KL by a NHMRC Senior Research Fellowship (grant number 1155005), and KLA by the Welcome Trust (grant number 224459/Z/21/Z).

Sections du résumé

BACKGROUND BACKGROUND
Dengue is the most important arboviral disease globally, and poses ongoing challenges for control including in non-endemic countries with competent mosquito vectors at risk of local transmission through imported cases. We examined recent epidemiological trends in imported and locally-acquired dengue in Australia, where the Wolbachia mosquito population replacement method was implemented throughout dengue-prone areas of northern Queensland between 2011-2019.
METHODS METHODS
We analysed dengue cases reported to the Australian National Notifiable Disease Surveillance System (NNDSS) between January 2012 and December 2022, and Australian traveller movement data.
RESULTS RESULTS
Between 2012 and 2022, 13 343 dengue cases were reported in Australia (median 1466 annual cases); 12 568 cases (94.2%) were imported, 584 (4.4%) were locally acquired and 191 (1.4%) had no origin recorded. Locally-acquired cases decreased from a peak in 2013 (n = 236) to zero in 2021-2022. Annual incidence of imported dengue ranged from 8·29/100000 (n = 917 cases) to 22·10/100000 (n = 2203) annual traveller movements between 2012 and 2019, decreased in 2020 (6·74/100000 traveller movements; n = 191) and 2021 (3·32/100000 traveller movements; n = 10) during COVID-19-related border closures, then rose to 34·79/100000 traveller movements (n = 504) in 2022. Imported cases were primarily acquired in Southeast Asia (n = 9323; 74%), Southern and Central Asia (n = 1555; 12%) and Oceania (n = 1341; 11%). Indonesia (n = 5778; 46%) and Thailand (n = 1483; 12%) were top acquisition countries. DENV-2 (n = 2147; 42%) and DENV-1 (n = 1526; 30%) were predominant serotypes.
CONCLUSION CONCLUSIONS
Our analysis highlights Australia's successful control of locally-acquired dengue with Wolbachia. Imported dengue trends reflect both Australian travel destinations and patterns and local epidemiology in endemic countries.
FUNDING BACKGROUND
AS is supported by a National Health and Medical Research (NHMRC) Postgraduate Scholarship (grant number 2002792), SLM by NHMRC Investigator Grants (grant number 2017229), KL by a NHMRC Senior Research Fellowship (grant number 1155005), and KLA by the Welcome Trust (grant number 224459/Z/21/Z).

Identifiants

pubmed: 38243558
pii: 7577676
doi: 10.1093/jtm/taae014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research
ID : 2002792
Organisme : NHMRC Investigator Grants
ID : 2017229
Organisme : NHMRC Senior Research Fellowship
ID : 1155005
Organisme : Welcome Trust
ID : 224459/Z/21/Z

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of International Society of Travel Medicine.

Auteurs

Asma Sohail (A)

School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria, Australia, 3004.
Infectious Diseases Department, Grampians Health Service, 1 Drummond Street North, Ballarat, Victoria, Australia, 3350.

Katherine L Anders (KL)

School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria, Australia, 3004.
World Mosquito Program, Monash University, 12 Innovation Walk, Clayton, Victoria, Australia, 3800.

Sarah L McGuinness (SL)

School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria, Australia, 3004.
Infectious Diseases Department, Alfred Health, 55 Commercial Road, Melbourne, Victoria, Australia, 3004.

Karin Leder (K)

School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria, Australia, 3004.
Victorian Infectious Diseases Service, Melbourne Health, 300 Grattan Street Parkville, Victoria, Australia, 3050.

Classifications MeSH